Transcript
Paul Walsh (0:00)
Welcome to Thoughts on the Market. I'm Paul Walsh, Morgan Stanley's head of European Research Product, and I'm joined by my colleagues Mike Wilson, Morgan Stanley's CIO and chief US Equity strategist, and Marina Zavolock, our chief European equity strategist. Investors are asking if Europe can sustain its recent stock market outperformance against the U.S. or if we're poised for a tactical reversal. And today's episode is going to be a special kind of face off, looking at the relative merits of our US Equity strategy views against our European stock market views as well. It's Wednesday, April 2nd at 9:30am in London. Our clients love the face off work that we do. And I think today we've really got the ultimate face off looking at the relative merits of our US Equity strategy views and our European stock market views as well. So when I think about year to date, Mike, so I'm going to start with you. Europe's obviously done pretty well. I mean, we've seen clearly defense and banks being the main thrust of that performance relative to the U.S. and when we look at U.S. equities, and I think this has been very consistent, honestly, with the views that you've been expressing since the start of the year. There's been weakness there driven by a range of factors that I think everybody listening in will understand and are well documented. But the key from my side is I sense you think there may be a tactical opportunity here and that we could be on the cusp of seeing something of a rotation back into US Equities. So I wanted to hear your views, how they're evolving, and if you think there's a real tactical opportunity here.
Mike Wilson (1:34)
I've not really been surprised at how the US Equity market has traded this year, given our view in the sequencing of policy. I think the surprise for me anyways is just how much Europe has gone up. And I think a lot of that just has to do with flows and flows of capital. So I mean, to me, the question for whether this is going to be, you know, kind of a structural change is like, what's really driving the outperformance in the near term? Is this something that is, you know, temporary, or is it something that's more secular and structural? And I think it's probably both. And, and the reality is is that it probably overshot a bit in the initial move here. And I want to just back up and kind of talk about the, you know, the US has been the, you know, the biggest outperformer for a decade, and it's been driven by, you know, kind of a handful of stocks or you know, the large cap growth segment. And I think it's interesting to just point out that that's a global phenomena, right? Meaning the high quality growth stocks in Europe have also done really, really well. It's just there's not as many of them. And similarly in Asia, the real story here is just that, you know, large cap quality growth and even somewhat defensive have just carried the day kind of post 2021 and but really over the last 10 years. And the question is why? Well, because, you know, organic growth has really not been that good. It's been very subsidized by government spending, other policy measures and you know, it's this crowding out feature that we've written about extensively. And that crowding out has led investors to essentially shun bonds and buy high quality stock. So now at the end of last year we had a couple of headwinds to this theme from a US Perspective. First off, the Fed stopped cutting interest rates in December. Number two, the fiscal impulse is reversing because it was unsustainable. The other one that doesn't get a lot of airtime, but some people have been talking about, including us is just the peak rate of change in AI CapEx really occurred in the fourth quarter and now it's decelerating. Doesn't mean we're up negative growth, it just means deceleration. But growth stocks key off of that. And that has driven revision breadth to be quite negative in the US for the first time really in several years and also on a relative basis. So I would argue that relative performance of Europe over the US Is really related directly to that relative earnings revision breath where Europe has been better relative to the US and then I think the bigger question is, is, you know, what happens after that. So we think there's, you know, another 3, 4 or 5% of relative value here for U.S. s and P500 over say Euro stacks in U.S. dollar terms. And then I guess I'd lastly just point out that the dollar itself was a big part of this move. The dollar euro exchange rate which was very strong at the end of last year and that was a headwind for earnings growth for U.S. companies and a tailwind for European companies that now is reversed as the dollar has weakened substantially against the euro. So I think Marina will talk about this as well. We believe that the relative earnings revision breadth between the US and Europe could reverse in Q1, really just on that currency exchange rate getting weaker now towards the dollar and Stronger for the euro.
